A Study of the Immunogenicity, Tolerability, & Safety of a New Formulation

See also
Status	Clinical Trial	Phase
Completed	`NCT01575197` - Evaluation of the Human Rotavirus Vaccine at Varying Schedules and Doses in Rural Ghana	Phase 4
Completed	`NCT01202201` - A Retrospective Survey of the Burden of Rotavirus Gastroenteritis (RV GE) and Nosocomial RV GE in Japan	N/A
Completed	`NCT00953056` - A Study of V260 in Healthy Chinese Adults, Children and Infants (V260-028)(COMPLETED)	Phase 1
Completed	`NCT00737503` - Introduction of an Oral Live Human Rotavirus (Rotarix) Vaccine in Matlab	Phase 4
Completed	`NCT04185545` - Efficacy, Safety and Immunogenicity of Rotavirus RV3 Vaccine (Bio Farma) in Neonates	Phase 3
Completed	`NCT03474055` - Study on Liquid Bovine Rotavirus Pentavalent Vaccine (LBRV-PV) to Evaluate Lot-to-Lot Consistency and to Compare Non-Inferiority With ROTASIIL (Lyophilized BRV-PV) in Healthy Infants in India	Phase 2/Phase 3
Completed	`NCT01236066` - Impact of Rotavirus Vaccination on Hospitalisations for Rotavirus Gastroenteritis in Children Aged <5 Years in Australia	N/A
Completed	`NCT00489567` - Hospital-based Surveillance to Collect Prospective Data to Estimate the Disease Burden of Severe RV GE in Sweden	N/A
Completed	`NCT02584816` - Phase III Study on Rotavirus Vaccine to Evaluate Lot-to-lot Consistency and Interference With Routine UIP Immunization	Phase 3
Completed	`NCT02062385` - Efficacy, Safety, and Immunogenicity of V260 in Healthy Chinese Infants (V260-024)	Phase 3
Completed	`NCT02133690` - A Clinical Trial to Study the Effect and Safety of Rotavirus Vaccine Against Severe Rotavirus Gastroenteritis in Healthy Indian Infants	Phase 3
Completed	`NCT01177657` - Study to Evaluate the Effectiveness of Rotarix™ Against Severe Gastroenteritis Among Hospitalized Children in Brazil	N/A
Completed	`NCT00740935` - Impact of Systematic Infants Vaccination Against Rotavirus on Gastroenteritis Hospitalization: a Prospective Study in Brest District, France.	Phase 4
Completed	`NCT01265355` - Community Based Prevention of Rotavirus Gastroenteritis by a Functional Food Supplement	Phase 2/Phase 3
Completed	`NCT00169455` - Assess the Immunogenicity of the Human Rotavirus (HRV) Vaccine After Reconstitution Without Buffering Agent; & Evaluate the Immunogenicity, Reactogenicity & Safety of the Vaccine After Storage for 7 d at 37°C Following 2 Doses in Healthy Infants	Phase 3
Completed	`NCT04819412` - To Determine the Safety and Efficacy of Liquid ROTAVAC 5C Vaccine Against Childhood Diarrhea Caused by Rotavirus	Phase 3
Completed	`NCT02728869` - Safety, Reactogenicity and Immunogenicity of Heat-stable Rotavirus Vaccine (HSRV) in Adults and Infants	Phase 1/Phase 2
Recruiting	`NCT05958771` - The Efficacy of Three Doses of Live Attenuated, Oral Rotavirus Vaccine 116E	Phase 3
Recruiting	`NCT01061658` - Safety and Immunogenicity Study of the Tetravalent Rotavirus Vaccine	Phase 1/Phase 2
Completed	`NCT01508533` - Epidemiology of Rotavirus Infection in North India Community	N/A

NCT number	NCT01600092
Study type	Interventional
Source	Merck Sharp & Dohme Corp.
Contact
Status	Completed
Phase	Phase 3
Start date	April 29, 2013
Completion date	March 25, 2014

A Study of the Immunogenicity, Tolerability, and Safety of a New Formulation of RotaTeq™ in Infants (V260-035)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms